MarketBeat summarized current ratings and price targets for Arcturus Therapeutics.
1 report, 1 independent
Updated Sep 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat summarized current ratings and price targets for Arcturus Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Arcturus Therapeutics
biotech company
-
MarketBeat
American personal finance blog
Related events
- MarketBeat provided an average rating and target price for Tenaya Therapeutics.
- MarketBeat has released its consensus rating and target price for Sunshine Biopharma, Inc.
- MarketBeat provided consensus price targets and ratings for Liquidia and Ovid Therapeutics.
- MarketBeat aggregated analyst recommendations and price targets for BioMarin Pharmaceutical and Abeona Therapeutics Inc.
- MarketBeat reported consensus price targets and analyst ratings for TScan Therapeutics and Mereo BioPharma Group.